Geode Capital Management’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.3M | Buy |
1,054,348
+88,598
| +9% | +$2.8M | ﹤0.01% | 1659 |
|
|
2025
Q1 | $32.1M | Buy |
965,750
+62,816
| +7% | +$2.09M | ﹤0.01% | 1635 |
|
|
2024
Q4 | $31.1M | Buy |
902,934
+167,516
| +23% | +$5.77M | ﹤0.01% | 1715 |
|
|
2024
Q3 | $29.4M | Sell |
735,418
-13,285
| -2% | -$532K | ﹤0.01% | 1769 |
|
|
2024
Q2 | $22.6M | Sell |
748,703
-5,074
| -0.7% | -$153K | ﹤0.01% | 1866 |
|
|
2024
Q1 | $25.3M | Buy |
753,777
+14,872
| +2% | +$499K | ﹤0.01% | 1779 |
|
|
2023
Q4 | $23.9M | Buy |
738,905
+19,529
| +3% | +$631K | ﹤0.01% | 1805 |
|
|
2023
Q3 | $23.6M | Buy |
719,376
+58,070
| +9% | +$1.9M | ﹤0.01% | 1719 |
|
|
2023
Q2 | $23.3M | Buy |
661,306
+87,681
| +15% | +$3.09M | ﹤0.01% | 1753 |
|
|
2023
Q1 | $18.7M | Buy |
573,625
+23,384
| +4% | +$763K | ﹤0.01% | 1846 |
|
|
2022
Q4 | $30.3M | Buy |
550,241
+19,957
| +4% | +$1.1M | ﹤0.01% | 1486 |
|
|
2022
Q3 | $23.5M | Buy |
530,284
+61,465
| +13% | +$2.72M | ﹤0.01% | 1614 |
|
|
2022
Q2 | $22.9M | Buy |
468,819
+27,205
| +6% | +$1.33M | ﹤0.01% | 1671 |
|
|
2022
Q1 | $21.5M | Buy |
441,614
+16,786
| +4% | +$817K | ﹤0.01% | 1855 |
|
|
2021
Q4 | $18.1M | Buy |
424,828
+13,718
| +3% | +$585K | ﹤0.01% | 2018 |
|
|
2021
Q3 | $15.8M | Buy |
411,110
+186,168
| +83% | +$7.14M | ﹤0.01% | 2126 |
|
|
2021
Q2 | $6.35M | Buy |
224,942
+124,185
| +123% | +$3.51M | ﹤0.01% | 2762 |
|
|
2021
Q1 | $3.33M | Buy |
100,757
+9,357
| +10% | +$309K | ﹤0.01% | 2986 |
|
|
2020
Q4 | $3.3M | Buy |
91,400
+44,904
| +97% | +$1.62M | ﹤0.01% | 2823 |
|
|
2020
Q3 | $1.58M | Buy |
+46,496
| New | +$1.58M | ﹤0.01% | 3003 |
|